Table 1.
Parameters | Units | Dose of IBI101 | |||
---|---|---|---|---|---|
0.1 mg/kg | 0.5 mg/kg | 2.5 mg/kg | 12.5 mg/kg | ||
Cmax | µg/mL | 3.07 ± 0.40 | 9.78 ± 3.27 | 63.10 ± 15.29 | 296.57 ± 58.05 |
Tmax | h | 0.08 ± 0.00 | 0.40 ± 0.78 | 0.08 ± 0.00 | 0.40 ± 0.78 |
AUC0-∞ | h × µg/mL | 347.98 ± 99.30 | 1429.19 ± 607.21 | 10,304.06 ± 3403.59 | 33,511.65 ± 14,982.36 |
t1/2 | H | 162.98 ± 103.01 | 129.47 ± 114.44 | 190.89 ± 92.94 | 120.30 ± 153.26 |
Cl | mL/h/kg | 0.31 ± 0.08 | 0.40 ± 0.14 | 0.27 ± 0.09 | 0.44 ± 0.20 |
MRTlast | h | 186.34 ± 110.68 | 136.03 ± 108.05 | 212.29 ± 114.61 | 114.93 ± 87.66 |
Values are mean ± SD
Cmax maximum drug concentration observed in serum, AUC0–∞, area under the concentration–time curve from time zero to the last measurable concentration, t1/2 effective half-time, which was calculated by terminal phase data harvested, MRTlast mean reaction time from time zero to the last measurable concentration